International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

The History of Pharmacology at the University of Liverpool | David Back

Video

HIV

Viral Hepatitis and Liver Disease

Therapeutic Drug Monitoring of Antiretrovirals – Is There a Future? | David Burger

Video

HIV

Viral Hepatitis and Liver Disease

Case Presentation: Unmasking the Enemy: Enzalutamide-Induced HIV Treatment Failure | Pierre Giguère

Video

HIV

Viral Hepatitis and Liver Disease

Development of Antiviral Drugs for COVID-19 in 2024: Endpoints and Unmet Needs | Simon Portsmouth

Video

HIV

Viral Hepatitis and Liver Disease

Gilead Sciences: HIV Drug Development Pipeline | Keith Dunn

Video

HIV

Viral Hepatitis and Liver Disease

Ainuovirine - A New-Generation Non-nucleoside Reverse Transcriptase Inhibitor | Harry H. Qin

Video

HIV

Viral Hepatitis and Liver Disease

Controversies and Consistencies Whether Men and Women Respond Differently to PrEP | Melanie Nicol

Video

HIV

Viral Hepatitis and Liver Disease

The Use of AI to Understand Complexity in HIV Care | Lauren Walker

Video

HIV

Viral Hepatitis and Liver Disease

Long-Acting Antiretroviral Delivery Intravaginally - Regional PBPK Models | Robert R. Bies

Video

HIV

Viral Hepatitis and Liver Disease

Micro-Array Patches | Lalitkumar Vora

Video

HIV

Viral Hepatitis and Liver Disease

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

The History of Pharmacology at the University of Liverpool | David Back

Therapeutic Drug Monitoring of Antiretrovirals – Is There a Future? | David Burger

The Evolution of Antiretroviral Tissue Pharmacokinetics | Angela DM Kashuba

Evolution of Long-Acting ARVs | Charles Flexner

Modelling Design and Validations for Complex LA Medicines | Simone Perazzolo

Optimizing TB Therapy for All Children | Rada Savic

Perinatal and Paediatric Considerations for LA Medicines | Adeniyi Olagunju

Regulatory Considerations for Emerging Infections | Kimberly Struble

Viral Haemorrhage Fevers - Recent Advances in Therapeutic Trials | Tom Fletcher

Drug-Drug Interactions in Specific Populations | Catia Marzolini

Case Presentation: Unmasking the Enemy: Enzalutamide-Induced HIV Treatment Failure | Pierre Giguère

Development of Antiviral Drugs for COVID-19 in 2024: Endpoints and Unmet Needs | Simon Portsmouth

Gilead Sciences: HIV Drug Development Pipeline | Keith Dunn

Ainuovirine - A New-Generation Non-nucleoside Reverse Transcriptase Inhibitor | Harry H. Qin

Controversies and Consistencies Whether Men and Women Respond Differently to PrEP | Melanie Nicol

The Use of AI to Understand Complexity in HIV Care | Lauren Walker

Long-Acting Antiretroviral Delivery Intravaginally - Regional PBPK Models | Robert R. Bies

Micro-Array Patches | Lalitkumar Vora

Models to Address Whether Men and Women Respond Differently to PrEP | Craig W. Hendrix